Stocks to Avoid
It's hard to justify these high prices.
When markets turn volatile, it can be increasingly difficult for investors to know which end is up. A stock that was undervalued in late September when the market bottomed might be overpriced today. Some highly leveraged companies might be great performers in a good economy. But in a recession, when their cash flows dry up--and the debt payments get hard to make--they might not look nearly as attractive.
In some cases, the choices are more clear-cut. Some companies like the five we're highlighting below are respected leaders in their industry segments. These companies have a lot going for them, whether it's strong growth, wide margins, or esteemed brand names. However, despite all their competitive advantages, the Morningstar analysts who track these stocks don't think they have enough going for them to justify their high prices, making them stocks to avoid.
Viacom : CBS's parent company needs another hit like Survivor to keep growth humming. Without it, we think this company might need to win an "immunity challenge" to protect its expensive stock.
E*Trade (ET): The online broker turned a profit in a difficult third quarter. But one good quarter does not a company make.
Baxter International (BAX): Sure, the big kahuna of medical devices will keep growing fast. But we don't think it can keep growing fast enough--for long enough--to stand behind the stock's high price.
FedEx (FDX): Yes, they ship packages very fast, but that requires a lot of capital spending. These heavy expenses make this a hard stock to like.
William Wrigley Jr. : This is a solid company with great products and strong brand names. Unfortunately, we believe that they'd have to sell a lot more Juicy Fruit than we think possible to approve the inflated price.
Craig Woker does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.